Establishment Labs sees FY25 revenue $210.5M-$211.5M, consensus $210.27M

“We had an excellent finish to 2025, with record quarterly revenue,” said Peter Caldini, Establishment Labs (ESTA)’ CEO. “Growth will continue in 2026 as our business accelerates towards being the industry standard. We continue to have positive adjusted EBITDA, and our cash position reflects our success in managing and improving the business. We expect to turn free cash flow positive later this year, and our operating leverage will become very evident in 2026 and beyond. I look forward to our meetings at the J.P. Morgan Healthcare Conference this week and presenting our full 2025 results on our February earnings call.”